Press Releases and Blog
Blog
PCMA Congratulates Dr. Mehmet Oz on His Confirmation to Lead the Centers for Medicare & Medicaid Services
(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) released a statement today following the U.S. Senate confirmation of Dr. Mehmet Oz, M.D. to serve
PBMs Work to Lower the Costs of GLP-1 Drugs
PBMs are facilitating coverage of these drugs for weight management, but Big Pharma companies are still shifting blame for their high prices onto PBMs.
PBMs Are Breaking Down Barriers to Expand Access to Biosimilars and Lower Consumer Costs
While Drug Companies Drive Up Drug Prices with Anti-Competitive Behavior, PBMs Continue to Innovate and Lower Costs for Consumers As policymakers tackle America’s prescription drug
PBMs Offer Innovative Cost-Sharing Programs to Address Patient Out-of-Pocket Costs
Lowering Patient Costs Leads to More Accessible and Affordable Prescription Drugs More than 92% of prescriptions cost patients less than $20 at the pharmacy counter;
ICYMI: JC Scott: PBMs Evolving to Meet Consumer Needs
In a new op-ed published in RealClearHealth, JC Scott, president and CEO of the Pharmaceutical Care Management Association (PCMA), highlights how PBMs are creating new, innovative programs to
PBMs Continue To Deliver Savings On Prescription Drugs For Patients
By negotiating directly with drug companies to lower prices, promoting competition, and managing prescription drug benefits efficiently, PBMs continue to be a critical force in
Press Releases
Arkansas Senate should Reject Dangerous Legislation
Arkansas Legislation would Force Pharmacy Closures and Jeopardize Arkansas Patients’ Access to Life-Saving Medications (Little Rock, AR) — The Pharmaceutical Care Management Association (PCMA), representing
PCMA Applauds Senators Cornyn, Grassley, Durbin, and Blumenthal Legislation Aimed At Cracking Down On Big Pharma’s Anti-Competitive Practices
Bills Would Encourage More Generic and Biosimilar Competition in the Rx Market to Help Lower Costs for Patients (Washington, D.C.) — The Pharmaceutical Care Management
Script Care Joins the Pharmaceutical Care Management Association
(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) today is announcing Script Care, Ltd. (SCL) as its newest member company. “The addition of Script Care to
MEDIA ADVISORY: Briefing with Pollster John McLaughlin On Public Opinion Research Finding Voters Oppose Pharma-Backed Government Intervention in the Private Market
(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) will host a press briefing from John McLaughlin of McLaughlin & Associates to discuss the results
McLaughlin Poll Finds Battleground Voters Oppose Pharma-Backed Government Intervention In The Private Market
Voters Support Holding Drug Companies Accountable to Strengthen America’s Health Care System (Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) today released the results
PCMA Launches PBM Innovation Project to Showcase New Patient-Centered Programs
PBMs Are Not Waiting for Government Mandates to Meet Evolving Market Needs (Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) launched the PBM Innovation
ICYMI: JC Scott: PBMs Evolving to Meet Consumer Needs
In a new op-ed published in RealClearHealth, JC Scott, president and CEO of the Pharmaceutical Care Management Association (PCMA), highlights how PBMs are creating new, innovative programs to
PBMs Continue To Deliver Savings On Prescription Drugs For Patients
By negotiating directly with drug companies to lower prices, promoting competition, and managing prescription drug benefits efficiently, PBMs continue to be a critical force in
Reminder: Small Businesses Prefer Flexibility and Options for Their Pharmacy Benefit Contracts
No employer or health plan sponsor is required to use a pharmacy benefit manager (PBM), but the vast majority voluntarily choose to because of the
ICYMI: Axios: 1 Big Thing: Q&A — PBM Lobby Chief On Path Ahead
In case you missed it, JC Scott, president and CEO of the Pharmaceutical Care Management Association (PCMA), sat down with Axios’ Peter Sullivan to discuss
Don’t Just Take Our Word for It: Academic Experts Assert the Value of PBMs and the Reality of Drug Pricing
Big Pharma continues to misconstrue the critical role and value that pharmacy benefit managers (PBMs) play in the prescription drug supply chain to drive down
Reminder: Rebates Have No Correlation With High Drug Prices
Conclusions across various reports have found that rebates secured by PBMs are NOT correlated to high and increasing list prices set solely by drug companies.
Reminder: Employers Value PBMs
Employers across the country recognize the critical role that pharmacy benefit managers (PBMs) play in providing affordable, flexible, and transparent prescription drug benefits. A recent survey
ICYMI: Former Chief Economist for House Ways and Means Committee Warns Against Government Intervention in the Private Health Market
In case you missed it, a leading economist is warning Congress against misguided government interventions in the private health care market that would boost Big
Big Pharma’s January Price Increases and Price Hikes on Popular Medications for Seniors Provide Reminder Drug Companies Set the Price
In case you missed it, Big Pharma kicked off the new year with price increases on hundreds of brand name drugs. These price hikes are
New Year, Same Fact: PBMs Play Critical Role Driving Down Health Costs
As Washington welcomes a new Congress, it’s a good time to revisit the critical, cost-saving role pharmacy benefit managers (PBMs) play in the prescription drug
